MTOR and cancer: In recent years, many in vitro studies have shown that TGF-β induced EMT into non-tumour epithelial cells though the activation of mTOR and PI3K pathways, leading to the apoptosis resistance of cancer cells, thereby promoting the trans-differentiation of CAFs [216].